Purvalanol, a specific CDK inhibitor with apoptosis inducing activity in breast cancer cells, also induced SSAT, APAO and SMO in MCF-7 and MDA-MB-231 breast cancer cells [74]. The gene discussed is SAT1; the disease is breast cancer.